These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23294549)

  • 61. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
    Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
    Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Vaginal estrogen supplementation during Depo-Provera initiation: a randomized controlled trial.
    Dempsey A; Roca C; Westhoff C
    Contraception; 2010 Sep; 82(3):250-5. PubMed ID: 20705153
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians.
    Kaunitz AM
    Int J Fertil Womens Med; 1998; 43(2):73-83. PubMed ID: 9609206
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Changes in key vaginal bacteria among postpartum African women initiating intramuscular depot-medroxyprogesterone acetate.
    Whitney BM; Guthrie BL; Srinivasan S; Tapia K; Muriuki EM; Chohan BH; Wallis JM; Liu C; McClelland RS; Fredricks DN; Roxby AC
    PLoS One; 2020; 15(3):e0229586. PubMed ID: 32134931
    [TBL] [Abstract][Full Text] [Related]  

  • 65. What Distinguishes Women Who Choose to Self-Inject? A Prospective Cohort Study of Subcutaneous Depot Medroxyprogesterone Acetate Users in Ghana.
    Nai D; Tobey E; Fuseini K; Kuma-Aboagye P; Jain A
    Glob Health Sci Pract; 2022 Feb; 10(1):. PubMed ID: 35294390
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Provider acceptability of Sayana® Press: results from community health workers and clinic-based providers in Uganda and Senegal.
    Burke HM; Mueller MP; Packer C; Perry B; Bufumbo L; Mbengue D; Daff BM; Mbonye A
    Contraception; 2014 May; 89(5):368-73. PubMed ID: 24576792
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The acceptability of self-administration of subcutaneous Depo-Provera.
    Lakha F; Henderson C; Glasier A
    Contraception; 2005 Jul; 72(1):14-8. PubMed ID: 15964286
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long-term effects of depot-medroxyprogesterone acetate on lipoprotein metabolism.
    Garza-Flores J; De la Cruz DL; Valles de Bourges V; Sanchez-Nuncio R; Martinez M; Fuziwara JL; Pérez-Palacios G
    Contraception; 1991 Jul; 44(1):61-71. PubMed ID: 1832626
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Follicular development and ovulation in extremely obese women receiving depo-medroxyprogesterone acetate subcutaneously.
    Segall-Gutierrez P; Taylor D; Liu X; Stanzcyk F; Azen S; Mishell DR
    Contraception; 2010 Jun; 81(6):487-95. PubMed ID: 20472115
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Physical findings and symptoms of depot medroxyprogesterone acetate use in adolescent females.
    Matson SC; Henderson KA; McGrath GJ
    J Pediatr Adolesc Gynecol; 1997 Feb; 10(1):18-23. PubMed ID: 9061630
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Current concepts regarding use of DMPA.
    Kaunitz AM
    J Reprod Med; 2002 Sep; 47(9 Suppl):785-9. PubMed ID: 12380407
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Acceptability of the distribution of DMPA-SC by community health workers among acceptors in the rural province of Lualaba in the Democratic Republic of the Congo: a pilot study.
    Mwembo A; Emel R; Koba T; Sankoko JB; Ngay A; Gay R; Bertrand JT
    Contraception; 2018 Nov; 98(5):454-459. PubMed ID: 30118683
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Patient's experience and satisfaction with self-administered subcutaneous depot medroxyprogesterone acetate use during the first year of COVID-19.
    Smith TJ; Urdanigo TK; Shroff N; Rubin SE
    Contraception; 2023 Jul; 123():110008. PubMed ID: 36931548
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparative pharmacokinetics and pharmacodynamics after subcutaneous and intramuscular administration of medroxyprogesterone acetate (25 mg) and estradiol cypionate (5 mg).
    Sierra-Ramírez JA; Lara-Ricalde R; Lujan M; Velázquez-Ramírez N; Godínez-Victoria M; Hernádez-Munguía IA; Padilla A; Garza-Flores J
    Contraception; 2011 Dec; 84(6):565-70. PubMed ID: 22078184
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Decline in bone mineral density with stress fractures in a woman on depot medroxyprogesterone acetate. A case report.
    Harkins GJ; Davis GD; Dettori J; Hibbert ML; Hoyt RA
    J Reprod Med; 1999 Mar; 44(3):309-12. PubMed ID: 10202754
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Home-based administration of Sayana® Press: review and assessment of needs in low-resource settings.
    Keith B; Wood S; Tifft S; Hutchings J
    Contraception; 2014 May; 89(5):344-51. PubMed ID: 24813924
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A cross-sectional study of the forearm bone mineral density in long-term current users of the injectable contraceptive depot medroxyprogesterone acetate.
    Viola AS; Castro S; Bahamondes MV; Fernandes A; Viola CF; Bahamondes L
    Contraception; 2011 Nov; 84(5):e31-7. PubMed ID: 22018135
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Depot medroxyprogesterone acetate pioneers. A retrospective study at a North Carolina Health Department.
    Potter LS; Dalberth BT; Cañamar R; Betz M
    Contraception; 1997 Nov; 56(5):305-12. PubMed ID: 9437559
    [TBL] [Abstract][Full Text] [Related]  

  • 80. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
    Contraception; 1982 Jan; 25(1):1-11. PubMed ID: 6460593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.